title: Tolerability of paracetamol.
abstract: The excellent tolerability of therapeutic doses of paracetamol (acetaminophen) is a major factor in the very wide use of the drug. The major problem in the use of paracetamol is its hepatotoxicity after an overdose. Hepatotoxicity has also been reported after therapeutic doses, but critical analysis indicates that most patients with alleged toxicity from therapeutic doses have taken overdoses. Importantly, prospective studies indicate that therapeutic doses of paracetamol are an unlikely cause of hepatotoxicity in patients who ingest moderate to large amounts of alcohol. Controlled clinical trials have found that paracetamol is very well tolerated by the gastrointestinal tract. While variable results have been found in case control studies, most studies have shown no change or a small increase in the relative risk of perforations, ulcer or bleeding in the upper gastrointestinal tract. However, associations between the use of paracetamol and gastrointestinal toxicity, as well as with chronic renal disease and asthma, are very likely to reflect biases in some case control studies. In particular, such biases may be caused by the perceived high tolerability of paracetamol in these diseases. The consequent use of paracetamol in these diseases states then leads to an apparent association between paracetamol and the disease. Despite metabolism of paracetamol to reactive compounds, hypersensitivity reactions are rare, although urticaria occurs in occasional patients. Paracetamol appears to be well tolerated during pregnancy although prospective studies are required.
authors.affiliation: Department of Clinical Pharmacology, St Vincent's Hospital, School of Medical Sciences, Sydney, Australia. ggraham@stvincents.com.au
authors.forename: Garry G
authors.initials: GG
authors.lastname: Graham
authors.forename: Kieran F
authors.initials: KF
authors.lastname: Scott
authors.forename: Richard O
authors.initials: RO
authors.lastname: Day
mesh_terms: D000082:Acetaminophen / Q000009:adverse effects* / Q000378:metabolism* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D006801:Humans; D015394:Molecular Structure; D016896:Treatment Outcome
chemical_list: D000082:Acetaminophen
references.citation: Gut. 1976 Nov;17(11):916-9
references.pmid: 1001981
references.citation: J Clin Psychiatry. 2001;62 Suppl 20:32-41
references.pmid: 11584873
references.citation: Am J Ther. 2000 Mar;7(2):99-114
references.pmid: 11319578
references.citation: Ann Intern Med. 2001 Feb 20;134(4):345
references.pmid: 11182855
references.citation: Therapie. 1990 Sep-Oct;45(5):438-9
references.pmid: 2260044
references.citation: Drug Saf. 2001;24(11):829-41
references.pmid: 11665870
references.citation: Clin Psychol Rev. 2001 Jul;21(5):797-811
references.pmid: 11434231
references.citation: Gut. 1982 Aug;23(8):692-7
references.pmid: 7095565
references.citation: Ann Allergy Asthma Immunol. 1997 Jul;79(1):47-50
references.pmid: 9236499
references.citation: Ann Allergy Asthma Immunol. 2000 Dec;85(6 Pt 1):508-11
references.pmid: 11152174
references.citation: Semin Arthritis Rheum. 1989 Aug;19(1):22-30
references.pmid: 2505388
references.citation: Br J Clin Pharmacol. 1991 Aug;32(2):143-9
references.pmid: 1931463
references.citation: Postgrad Med. 2000 Jan;107(1):189-95
references.pmid: 10649673
references.citation: Arthritis Rheum. 1993 Jan;36(1):84-90
references.pmid: 8424842
references.citation: Cell. 1997 Oct 17;91(2):197-208
references.pmid: 9346237
references.citation: Adv Exp Med Biol. 1991;283:51-64
references.pmid: 2069022
references.citation: Arthritis Res. 2001;3(2):98-101
references.pmid: 11178116
references.citation: Am J Obstet Gynecol. 2002 Sep;187(3):653-60
references.pmid: 12237643
references.citation: Toxicol Appl Pharmacol. 1981 Nov;61(2):252-9
references.pmid: 6798713
references.citation: Clin Pharmacol Ther. 2000 Mar;67(3):275-82
references.pmid: 10741631
references.citation: Br J Clin Pharmacol. 2000 Apr;49(4):291-301
references.pmid: 10759684
references.citation: Am J Med. 1983 Jun 14;74(6A):79-82
references.pmid: 6602547
references.citation: Arch Intern Med. 2001 Oct 8;161(18):2247-52
references.pmid: 11575982
references.citation: Clin Exp Allergy. 2002 Sep;32(9):1366-9
references.pmid: 12220477
references.citation: Blood. 2001 Jun 15;97(12):3846-50
references.pmid: 11389025
references.citation: Br J Dermatol. 2000 Nov;143(5):1055-8
references.pmid: 11069520
references.citation: Lancet. 1998 Jan 10;351(9096):104-7
references.pmid: 9439495
references.citation: Br J Clin Pharmacol. 2002 Sep;54(3):320-6
references.pmid: 12236853
references.citation: Drug Saf. 2002;25(9):619-24
references.pmid: 12137556
references.citation: Am J Ther. 2000 Mar;7(2):55-61
references.pmid: 11319574
references.citation: Pharm Res. 1989 Apr;6(4):265-73
references.pmid: 2664753
references.citation: Chem Biol Interact. 1988;64(3):251-66
references.pmid: 3124965
references.citation: Ann Pharmacother. 2003 Oct;37(10):1497-501
references.pmid: 14519044
references.citation: Am J Gastroenterol. 1998 Jul;93(7):1051-4
references.pmid: 9672328
references.citation: Int J Cancer. 2002 Jan 1;97(1):96-101
references.pmid: 11774249
references.citation: BMJ. 2003 Aug 16;327(7411):368
references.pmid: 12919986
references.citation: Clin Pharmacol Ther. 2000 Jun;67(6):591-9
references.pmid: 10872641
references.citation: Toxicol Lett. 2001 Mar 31;120(1-3):199-208
references.pmid: 11323178
references.citation: Arthritis Rheum. 2001 Oct;44(10):2449; author reply 2455-6
references.pmid: 11665990
references.citation: J Toxicol Clin Toxicol. 2002;40(1):3-20
references.pmid: 11990202
references.citation: Ann N Y Acad Sci. 2001 Apr;932:200-21; discussion 221-4
references.pmid: 11411187
references.citation: Scand J Rheumatol Suppl. 1998;107:128-32
references.pmid: 9759151
references.citation: Arthritis Rheum. 2001 Oct;44(10):2448-9; author reply 2455-6
references.pmid: 11665988
references.citation: Am J Ther. 2002 May-Jun;9(3):199-205
references.pmid: 11941379
references.citation: N Engl J Med. 2001 Dec 20;345(25):1801-8
references.pmid: 11752356
references.citation: Am J Gastroenterol. 1985 Oct;80(10):767-9
references.pmid: 4036935
references.citation: Am J Ther. 2002 May-Jun;9(3):225-33
references.pmid: 11941382
references.citation: Thorax. 2000 Apr;55(4):266-70
references.pmid: 10722764
references.citation: Am J Hematol. 1994 Mar;45(3):258-9
references.pmid: 8296799
references.citation: Gut. 1999 Feb;44(2):270-3
references.pmid: 9895389
references.citation: Eur J Clin Pharmacol. 1979 Jul;15(6):427-31
references.pmid: 499292
references.citation: Arch Intern Med. 2002 Oct 28;162(19):2204-8
references.pmid: 12390063
references.citation: Hepatology. 1994 May;19(5):1141-8
references.pmid: 8175135
references.citation: Arthritis Rheum. 2000 Sep;43(9):1905-15
references.pmid: 11014340
references.citation: BMJ. 1995 Apr 1;310(6983):827-30
references.pmid: 7711618
references.citation: Curr Pharm Des. 2002;8(12):1063-75
references.pmid: 11945151
references.citation: Presse Med. 2001 Apr 21;30(15):724-30
references.pmid: 11360737
references.citation: Thromb Res. 1989 Mar 15;53(6):603-13
references.pmid: 2499947
references.citation: Arthritis Rheum. 2002 Nov;46(11):3046-54
references.pmid: 12428249
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4611-6
references.pmid: 11287661
references.citation: Ir J Med Sci. 2001 Apr-Jun;170(2):94-7; discussion 90
references.pmid: 11491059
references.citation: Am J Kidney Dis. 1996 Jul;28(1 Suppl 1):S14-9
references.pmid: 8669423
references.citation: Med J Aust. 1999 Nov 1;171(9):472-5
references.pmid: 10615340
references.citation: Inflammopharmacology. 1999;7(3):255-63
references.pmid: 17638096
references.citation: Drug Saf. 1992;7 Suppl 1:51-6
references.pmid: 1503678
references.citation: Am J Ther. 2000 Mar;7(2):123-34
references.pmid: 11319580
references.citation: J Biol Chem. 1987 Jan 25;262(3):974-80
references.pmid: 3100532
references.citation: Clin Pharmacol Ther. 1983 Jan;33(1):95-101
references.pmid: 6848304